We are convinced that early detection of diseases is the prerequisite for better treatment options and thus optimal chances of recovery.
That is why we are driven by the vision of making chronic health imbalances diagnosable even before the disease can manifest itself. This is the prerequisite for turning the early detection of life-changing diseases such as cancer, Alzheimer’s or diabetes into true prevention.
Our aim is to make our diagnostics as simple, cost-effective, and burden-free as possible so that as many people as possible can benefit from them.
Imprint: https://www.zyagnum.com/en/imprint/
Privacy Policy: https://bit.ly/3d1YHzO
Company Details
- Employees
- 23
- Founded
- -
- Address
- Gräfenhäuser Straße, Darmstadt,hesse 64293,germany
- Industry
- Biotechnology
- Website
- zyagnum.com
- Keywords
- Biotechnology, Diagnostics, Cancer screening, New generation flow cytometry, Universal cancer test, EDIM Detect, EDIM Technology, Illuminizer.
- HQ
- Darmstadt, Hesse
Zyagnum Ag Questions
Zyagnum Ag's website is zyagnum.com
Zyagnum Ag's LinkedIn profile is https://de.linkedin.com/company/zyagnum-ag
Zyagnum Ag has
23 employees.
View email and phone details for 23
employees at Zyagnum Ag.
Zyagnum Ag's industry is
Biotechnology
Zyagnum Ag's top competitors are
Deutsche Telekom,
Sinnflimmern,
Löwenstein Medical,
R-Biopharm Group,
Pantum Detect®,
Benfovir Ag,
Mpdv Mikrolab Gmbh,
Dr Patel Consulting,
Swytch Digitalmanufaktur Gmbh,
R-Biopharm Ag.
Zyagnum Ag's categories are Biotechnology
Zyagnum Ag's founding year is 2007
